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SUPPLEMENTARY MATERIALS & METHODS

Reagents
Afatinib and cetuximab were obtained from ChemieTek (Indianapolis, IN, USA) and Bristol-Myers Squibb (New York, NY, USA), respectively. WZ4002 compound was a kind gift from Dr. Nathanael S. Gray (Harvard Medical School, Boston, MA, USA). Erlotinib was obtained from LC Laboratories (Woburn, MA, USA). Primary antibodies for EGFR (L858R mutant specific, 43B2), P-EGFR (Tyr1173, 53A5), P-EGFR (Tyr1068, D7A5), EGFR, P-Akt (Ser473, D9E), P-p44/42 MAPK (Erk1/2) (Thr202/Tyr204, 20G11), P-S6 Ribosomal Protein (Ser235/236, D57.2.2E) were from Cell Signaling Technology (Beverly, MA, USA). Anti α-Tubulin and β-Actin (JLA20) antibodies were from Sigma (St. Louis, MO, USA) and Calbiochem (Gibbstown, NJ, USA), respectively. Anti Mucin 1 (H-295), TTF-1 (8G7G3/1), and SP-C (FL-197) antibodies were from Santa Cruz biotechnology (Santa Cruz, CA, USA).
Immunoblotting analysis (IB)
Cells ( 
Immunohistochemical analysis (IHC)
Expression of mutant EGFR L858R+T790M (mEGFR L+T ) was confirmed by IB and IHC with an antibody of EGFR (L858R mutant specific, 43B2). A formalin-fixed with decalcification, paraffin-embedded (FFPE) mouse skull was sectioned, placed on slide, and stained with hematoxylin and eosin (H&E) (Histoserv Inc. Germantown, MD, USA). Antigen retrieval was carried out using preheated target retrieval solution (pH 6.0) from DakoCytomation (Carpinteria, CA, USA) for 30 minutes in a boiling rice cooker. Vectastain Elite ABC kits from Vector Laboratories (Burlingame, CA, USA) were used according to manufacturer's instructions for blocking, dilution of primary antibody, and labeling. Primary antibody was incubated with sections for 16 hours at 4°C. 3,3-Diaminobenzidine was prepared fresh from tablets (Sigma).
Specificity of staining was assessed by comparison with both samples stained in the absence of primary antibody and FFPE cell pellets from human non-small cell lung cancer (NSCLC) H1975 cells expressing mEGFR L+T protein.
Magnetic resonance imaging (MRI) Scanning and total tumor volume measurement
Anesthesia was induced then maintained with 1%-2% isoflurane administered via nosecone in an imaging chamber, and mice with vitals and body core temperature maintained were placed in a 72/25 mm volume/surface coil ensemble and positioned in a 7T horizontal MRI scanner. T 2 weighted anatomical images, encompassing the whole brain, were acquired in the coronal and horizontal planes (resolution= 75x75x750 µm, TR/TE= 2500/24 ms). Formalin-fixed cells were sent to Histoserv Inc. and processed for FFPE pellets.
Sequencing of von Hippel-Lindau (Vhl) gene
For DNA preparation, the entire ear tumor pieces from SP-C/mEGFR L+T mice were dissected and flash-frozen followed by stored at -70 ○ C until being used. 
